Stockscreener 앱 받기
14.81
0.82%
0.1471
전일 마감가:
$14.66
열려 있는:
$14.75
하루 거래량:
39,936
Relative Volume:
0.10
시가총액:
$748.37M
수익:
$62.02M
순이익/손실:
$-45.65M
주가수익비율:
-16.09
EPS:
-0.92
순현금흐름:
$-9.60M
1주 성능:
+3.36%
1개월 성능:
+2.57%
6개월 성능:
+42.53%
1년 성능:
+78.50%
1일 변동 폭
$14.75
$14.97
1주일 범위
$13.95
$14.97
52주 변동 폭
$7.90
$15.15
Theravance Biopharma Inc Stock (TBPH) Company Profile
명칭
Theravance Biopharma Inc
전화
650-808-6000
주소
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
TBPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TBPH
Theravance Biopharma Inc
|
14.86 | 738.30M | 62.02M | -45.65M | -9.60M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.50 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
638.23 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.90 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.39 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.24 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-12 | 개시 | B. Riley Securities | Buy |
| 2024-08-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-04-12 | 개시 | BTIG Research | Buy |
| 2024-01-08 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2021-11-05 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2021-08-25 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2021-08-24 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-10-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-07 | 개시 | JP Morgan | Overweight |
| 2020-06-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-05-13 | 개시 | Cowen | Outperform |
| 2020-01-08 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-06 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2019-10-29 | 개시 | H.C. Wainwright | Buy |
| 2018-03-29 | 재개 | Piper Jaffray | Overweight |
| 2017-08-17 | 개시 | Evercore ISI | Outperform |
| 2017-06-16 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-11 | 재확인 | Needham | Buy |
| 2016-12-21 | 개시 | Needham | Buy |
| 2016-11-03 | 개시 | Piper Jaffray | Overweight |
| 2016-10-12 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2016-08-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2016-06-20 | 개시 | Guggenheim | Buy |
| 2016-06-20 | 재확인 | Leerink Partners | Outperform |
| 2016-05-12 | 개시 | Leerink Partners | Outperform |
| 2016-05-05 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2015-02-03 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
모두보기
Theravance Biopharma Inc 주식(TBPH)의 최신 뉴스
Will a bounce in Theravance Biopharma Inc. offer an exitQuarterly Profit Review & Capital Efficiency Focused Strategies - newser.com
Can Theravance Biopharma Inc. stock maintain operating marginsWeekly Trend Report & Community Trade Idea Sharing Platform - newser.com
What consensus target says about Theravance Biopharma Inc. (0TB) stockInflation Watch & Verified Short-Term Trading Plans - newser.com
Is Theravance Biopharma Inc. (0TB) stock a momentum leaderTreasury Yields & Safe Capital Growth Tips - newser.com
Can Theravance Biopharma Inc. (0TB) stock sustain revenue momentum2025 Dividend Review & Community Driven Trade Alerts - newser.com
Can Theravance Biopharma Inc. stock deliver consistent earnings growth2025 EndofYear Setup & Trade Opportunity Analysis Reports - newser.com
Can Theravance Biopharma Inc. (0TB) stock hit consensus price targets2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Why Theravance Biopharma Inc. (0TB) stock benefits from AI revolutionMarket Performance Recap & Reliable Breakout Forecasts - newser.com
Why Theravance Biopharma Inc. stock is in analyst buy zone2025 Support & Resistance & Reliable Breakout Forecasts - newser.com
Why Theravance Biopharma Inc. (0TB) stock remains stableJuly 2025 Sentiment & Fast Exit Strategy with Risk Control - newser.com
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Theravance Biopharma Inc. stock trendline breakdownJuly 2025 PostEarnings & Real-Time Buy Zone Alerts - newser.com
Will Theravance Biopharma Inc. stock see insider buyingAnalyst Upgrade & Technical Pattern Based Signals - newser.com
Can Theravance Biopharma Inc. stock attract ESG capital inflowsJuly 2025 Intraday Action & Daily Entry Point Alerts - newser.com
How to escape a deep drawdown in Theravance Biopharma Inc.July 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com
What to expect from Theravance Biopharma Inc. in the next 30 daysIPO Watch & Weekly Chart Analysis and Trade Guides - newser.com
Theravance Biopharma, Inc. (TBPH) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Buy? - sharewise.com
Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System - Lelezard
Theravance Biopharma Inc (TBPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.21%
0.74%
자본화:
|
볼륨(24시간):